ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Health Benefits of Manuka Honey

Increase Your Magnesium Intake

Vitamin D supplementation could ease IBS symptoms

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Curcumin Supplementation May Impart Long-Term Cognitive Benefits

Vitamin D deficiency during pregnancy can program obesity in children

Print Page
Email Article

Harris Fibromyalgia Global Impact Survey Depicts Serious Patient Burden - Lack of Physician Education May Contribute to Problem

  [ 36 votes ]   [ 2 Comments ]
By European Network of Fibromyalgia Associations (ENFA) • • June 22, 2008

"These survey findings are so important because they expose the challenges facing people living with Fibromyalgia and validate the tremendous impact of the condition on their lives." ENFA President Robert Boelhouwer PARIS, June 13 - A new global survey of Fibromyalgia patients and physicians shows that Fibromyalgia, a chronic widespread pain condition, results in poor quality of life and poses a financial burden on patients, often resulting in an inability to work and earn income.

The burden of Fibromyalgia may be further compounded by the fact that in most countries it takes patients on average 1.9 to 2.7 years, and between 2 and 4 physicians to receive an accurate diagnosis.

According to the survey, lack of physician confidence in recognizing symptoms of the condition may be contributing to delays in diagnosis.

These new survey findings were released [June 13] by the European Network of Fibromyalgia Associations (ENFA), a coalition of patient advocacy organizations, and Pfizer Inc, and include findings from the UK, France, Germany, Italy, Spain, the Netherlands, Mexico and S. Korea.

Poor Quality of Life for Patients with Fibromyalgia

  • In all countries surveyed, patients with Fibromyalgia say they experience 6 to 11 symptoms on average, including chronic widespread pain, sleep disturbance, fatigue and sensitivity to touch.
  • Many of the symptoms are described by patients as extremely or very disruptive to the overall quality of their lives.
  • Patients say the areas of their lives that are most affected are physical mobility, overall mood, concentration and memory, and motivation and drive.

Financial Burden of Fibromyalgia

Fibromyalgia places a financial burden on patients and can result in missed work days and limited ability or inability to work.

  • Across all European countries surveyed, at least 1 in 5 patients said they have been unable to work and earn an income.
  • Furthermore, one third of patients in Spain, more than in any other country surveyed, claim they lost their jobs due to Fibromyalgia.
  • In most countries, around half of all patients say they have missed 10 or more days of work over the last year.

Diagnosis Can Take Years

The survey shows that for patients with Fibromyalgia, a diagnosis may take years for a number of reasons.

  • Patients in this survey waited an average of 5 months (UK) to 1.5 years (Mexico) to consult a physician about their symptoms because they thought their symptoms would go away or they could manage them on their own.
  • Once patients have consulted a physician, it can take, on average, 1.9 to 2.7 years and between 2 and 4 physicians to receive an accurate diagnosis.
  • In Spain, this process was even longer (3.7 years).

"These survey findings are so important because they expose the challenges facing people living with Fibromyalgia and validate the tremendous impact of the condition on their lives," says Robert Boelhouwer, President of the European Network of Fibromyalgia Associations (ENFA). "It is my hope that these new data will prompt a dialogue about steps that can be taken to improve diagnosis and management of Fibromyalgia so we can reduce the enormous burden of this chronic pain condition."

Physicians Lack Confidence in Diagnosing Fibromyalgia

Contributing to the lengthy process of diagnosis may be physicians' lack of confidence in diagnosing Fibromyalgia.

  • Interestingly, this problem was not exclusive to primary care physicians, since specialists surveyed also report significant difficulties diagnosing Fibromyalgia.
  • In fact, between 16% (Mexico) and 71% (Korea) of all physicians surveyed say they are not very or not at all confident in recognizing symptoms of Fibromyalgia.
  • Between 25% (Mexico) and 73% (Korea) of physicians also say they are not very or not at all confident in their ability to differentiate symptoms of Fibromyalgia from other conditions.

According to the survey, insufficient training of physicians may contribute to the problem. As a result, it was not surprising to see that a significant proportion of physicians in all countries report the condition is often or almost always misdiagnosed.

"The survey findings are worrying because they suggest that physicians lack knowledge and training in managing patients with Fibromyalgia, which is most certainly contributing to delays in the diagnosis and treatment of the condition," said Ernest Choy MD, Department of Rheumatology, GKT School of Medicine, King's College, London (UK). "It is important that the medical community and policy makers now take the necessary steps to provide physicians with the education and training they need to properly and confidently manage patients with Fibromyalgia."

About Fibromyalgia

Fibromyalgia is one of the most common, chronic widespread pain conditions and affects between 16 and 40 million people worldwide. Fibromyalgia is usually accompanied by poor sleep, stiffness and fatigue along with other co-morbidities. Fibromyalgia is more prevalent in women, who account for 87 percent of diagnosed cases; however, men can also be affected.

The exact causes of Fibromyalgia are not yet known. Some scientists believe that there is an abnormality in how the body responds to pain, particularly a heightened sensitivity to stimuli. A growing body of evidence suggests that alterations in the central nervous system may contribute to the pain of Fibromyalgia.

About the Survey

The European Network of Fibromyalgia Associations (ENFA) and Pfizer Inc. partnered to develop the Fibromyalgia Global Impact Survey to advance understanding and aid diagnosis of Fibromyalgia. The independent polling organization Harris Interactive conducted the survey. The survey was supported by Pfizer Inc.

The survey included 800 diagnosed Fibromyalgia patients and 1,622 physicians total from eight countries: the UK, France, Germany, Italy, Spain, the Netherlands, Mexico and S. Korea.

In each country, 100 diagnosed Fibromyalgia patients, approximately 100 PCPs (primary care physicians) and approximately 100 specialists (25 rheumatologists, 25 neurologists, 25 pain specialists and 25 psychiatrists) were interviewed.

Of the 1,622 physicians surveyed, 1,294 had treated Fibromyalgia patients in the last 2 years and 328 had not. Patients who participated in the survey were 18 years of age or older with the highest percentage of patients (ranging from 30% in Spain and 46% in Mexico) being between 45-59 years of age. Both females (n=675) and males (n=125) were included in the survey. Data collection was conducted from February 25, 2008 through April 17, 2008.

About the European Network of Fibromyalgia Associations (ENFA)

The European Network of Fibromyalgia Associations (ENFA) was formed in September 2004 to increase awareness of Fibromyalgia in Europe and provide support and information to patients and caregivers. There are currently 11 countries part of ENFA, including the UK, Spain, France, Belgium, Netherlands, Germany, Italy, Denmark, Sweden, Portugal and Israel.

Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Ultra ATP+, Double Strength Energy NADH™ 12.5mg

Article Comments Post a Comment

Harris FM Global Impact Survey
Posted by: Pearls
Jul 3, 2008
I'm so glad that this study has been done, and I hope there will be more like it. I've had fibromyalgia since 2000, and had to retire early from my teaching job. This will have cost me many thousands of dollars over my lifetime. I had not reached 30 years of service so my retirement income was sharply reduced from what it would have been. Thank God for my doctors! It gets lonely in Fibromyalgia Land, and they have helped me on the treacherous path through its territory. I wished, in the first years, for some kind of educational/theraputic program to which I could go weekly, instead of only seeing my pain specialist monthly. He was my lifeline, and I was scared on my own. -Pearl
Reply Reply

Fiblrmyalgia and phenophthalein
Posted by: shaggy012
Jun 8, 2010
In 1988, I bacame very ill after a large phenolphthalein overdose. A co-worker had played a prank on me. The long term symptoms were similar to FM and chronic fatigue syndrome. Over 10 years later, I had elavated liver enzymes. I also developed karataconus and had to have eye surgery. Most doctors would not acknoweledge anything was really wrong. One doctor even tried to convince me that the phenolphthalein overdose could not have made me that sick. But the information I found said it may be fatal. One thing I found that seemed to help me was sam-e.(helped headaches and general pain. Helped digestion) Another was valarien root (to help me sleep) Also lots of vegie juice. That was over 20 years ago. Today I am still mot 100% recovered, but now I feel like I am well on my way.
Reply Reply
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Sleep Like a Baby in Nature's Cradle Sleep Like a Baby in Nature's Cradle
Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map